Good Start Genetics, PerkinElmer Collaboration Expands Access to Genetic Carrier Screening Tests
News Mar 17, 2014
GoodStart Select is a menu of genetic carrier screening tests offered by Good Start Genetics that uses sophisticated technologies, including proprietary next-generation DNA sequencing (NGS), to provide highly accurate and clinically actionable genetic information to reproductive partners planning a pregnancy. Test results by GoodStart Select have been shown to provide higher mutation detection rates and fewer missed carriers than traditional screening technologies.
"Our continued success with GoodStart Select in the IVF setting demonstrates the clinical value of our robust menu of tests for guideline-recommended genetic disorders. We are excited that PerkinElmer has chosen GoodStart Select as their genetic carrier screening offering of choice," said Don Hardison, president and chief executive officer of Good Start Genetics. “Collaborating with PerkinElmer will allow us to reach more of the 60 million reproductive age women who are candidates for genetic carrier screening, and ultimately help more couples better assess their risks of, and options to avoid, having a baby with a debilitating or fatal inherited genetic disorder ."
Under the terms of the collaboration agreement, PerkinElmer will serve as the exclusive commercial partner of Good Start Genetics in the sales and marketing of GoodStart Select to targeted OBGYN and MFM physicians in the United States. The collaboration expands access to the GoodStart Select tests to ordering physicians that are not within Good Start Genetics’ current commercial market of in vitro fertilization and broadens PerkinElmer’s extensive prenatal screening menu to include the highly-validated genetic carrier screening tests included in the GoodStart Select menu.
"PerkinElmer is committed to offering innovative prenatal screening technology as part of our comprehensive diagnostics portfolio,” said Jim Corbett, president, Human Health, PerkinElmer. “GoodStart Select further expands our maternal fetal health offerings and enables us to provide even more meaningful tools and clinically actionable information and insights to physicians and patients. We look forward to working with Good Start Genetics to extend genetic carrier screening options for those persons planning a pregnancy.
Professional societies, including the American Congress of Obstetricians & Gynecologists (ACOG), the American College of Medical Genetics and Genomics (ACMG) and national Jewish advocacy societies have published recommendations for carrier screening to detect potential genetic disorders that are relatively common in certain ethnicities. GoodStart Select is designed to identify known, pathogenic mutations for all inherited genetic disorders recommended for testing by the leading reproductive medicine societies and influential advocacy groups, irrespective of a patient’s ethnicity. By arming physicians and patients with this personalized genetic information, GoodStart Select can help reproductive partners to better assess their risk of, and options to avoid, having a child with a debilitating or fatal inherited genetic disorder.
"Genetic Jenga" Helps Understand How Our Genes Control Our CellsNews
To fully understand how our cells work, we can't focus on just one gene, but must instead look at combinations of genes. Researchers have published a study which knocked out multiple genes, like removing bricks from a Jenga tower, to better understand how they work together.READ MORE
Southeast Asian Nomads Have Evolved to Hunt Fish UnderwaterNews
The human spleen can release oxygenated blood cells to allow more time underwater without breathing. A new study has identified that the "Sea Nomad" Bajau people of Indonesia have evolved larger spleens that would allow them to remain underwater for longer.READ MORE
Gene Therapy Could End Transfusions for Blood Disorder PatientsNews
Beta-thalassemia patients need a regular dose of red blood cells transfused into their body. A new gene therapy that edits faulty genes in the patients' cells could end this monthly ritual.READ MORE
Comments | 0 ADD COMMENT
2nd International Conference and Exhibition on Nanomedicine and Drug Delivery
May 21 - May 23, 2018
World Congress on Advanced Biomaterials and Tissue Engineering
Jun 20 - Jun 21, 2018
International Conference on Epigenetics and Epitranscriptomics
Sep 17 - Sep 18, 2018